Stock Events

Stock Events

TransCode Therapeutics (RNAZ) Q2 2024 Earnings

15MayConfirmed

Aug 22

Nov 22

Q4 2022

Q2 2024

-0.7

-0.47

-0.23

0

Details

Expected EPS

-0.7

Actual EPS

-0.65

Surprise EPS

0.05

Surprise Percent

+7.14%

Description

TransCode Therapeutics (RNAZ) has reported earnings of -0.65 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.